Xiong HH - Search Results

1

[Result of phase II clinical trial of herceptin in advanced Chinese breast cancer patients].

Sun Y, Li LQ, Song ST, Xu LG, Yu SY, Wang JW, Jiang ZF, Yin JL, Xiong HH. Sun Y, et al. Among authors: xiong hh. Zhonghua Zhong Liu Za Zhi. 2003 Nov;25(6):581-3. Zhonghua Zhong Liu Za Zhi. 2003. PMID: 14690567 Clinical Trial. Chinese.

2

[First-line Xeloda (Capecitabine) treatment for advanced and recurrent colorectal cancer].

Guan ZZ, Liu DG, Yu BM, Wu WQ, Shi D, Zhao Y, Wei YQ, Zou LQ, Wu XD, Zhuang W, Feng FY, Zhang P, Yu SY, Xiong HH, Fu Q, Zheng S, Huang JJ, Wu G, Yang CY, Sun SR, Ruan QL. Guan ZZ, et al. Among authors: xiong hh. Zhonghua Zhong Liu Za Zhi. 2004 Feb;26(2):119-21. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15059335 Chinese.

3

[Expression of thymidine phosphorylase in cancer].

Jiang LN, Yu SY, Xiong HH, Zhang MX. Jiang LN, et al. Among authors: xiong hh. Zhonghua Zhong Liu Za Zhi. 2004 May;26(5):297-9. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15312368 Chinese.

4

Effects of Survivin expression suppressed by short hairpin RNA on MCF-7 cells.

Xiong H, Yu S, Hu G, Zhuang L. Xiong H, et al. J Huazhong Univ Sci Technolog Med Sci. 2006;26(3):305-7. doi: 10.1007/BF02829558. J Huazhong Univ Sci Technolog Med Sci. 2006. PMID: 16961276

5

Changes of survivin mRNA and protein expression during paclitaxel treatment in breast cancer cells.

Xiong H, Yu S, Zhuang L, Xiong H. Xiong H, et al. J Huazhong Univ Sci Technolog Med Sci. 2007 Feb;27(1):65-7. doi: 10.1007/s11596-007-0119-9. J Huazhong Univ Sci Technolog Med Sci. 2007. PMID: 17393113

6

[Potentials of DNA-PKcs, Ku80, and ATM in enhancing radiosensitivity of cervical carcinoma cells].

Zhuang L, Yu SY, Huang XY, Cao Y, Xiong HH. Zhuang L, et al. Among authors: xiong hh. Ai Zheng. 2007 Jul;26(7):724-9. Ai Zheng. 2007. PMID: 17626748 Free article. Chinese.

7

Suppression of DNA-PKcs and Ku80 individually and in combination: Different effects of radiobiology in HeLa cells.

Zhuang L, Cao Y, Xiong H, Gao Q, Cao Z, Liu F, Qiu H, Yu S, Huang X. Zhuang L, et al. Int J Oncol. 2011 Aug;39(2):443-51. doi: 10.3892/ijo.2011.1041. Epub 2011 May 13. Int J Oncol. 2011. PMID: 21573502

8

Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study.

Yang L, Shi L, Fu Q, Xiong H, Zhang M, Yu S. Yang L, et al. Oncol Lett. 2012 Apr 1;3(4):935-939. doi: 10.3892/ol.2012.585. Epub 2012 Jan 31. Oncol Lett. 2012. PMID: 22741022 Free PMC article.

9

Notch signaling: an emerging therapeutic target for cancer treatment.

Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K. Yuan X, et al. Cancer Lett. 2015 Dec 1;369(1):20-7. doi: 10.1016/j.canlet.2015.07.048. Epub 2015 Sep 1. Cancer Lett. 2015. PMID: 26341688 Free article. Review.

10

Poor-prognosis disclosure preference in cancer patient-caregiver dyads and its association with their quality of life and perceived stress: a cross-sectional survey in mainland China.

Nie X, Ye D, Wang Q, Manyande A, Yang L, Qiu H, Chao T, Zhang P, Gong C, Zhuang L, Yu S, Xiong H. Nie X, et al. Psychooncology. 2016 Sep;25(9):1099-105. doi: 10.1002/pon.4055. Epub 2015 Dec 7. Psychooncology. 2016. PMID: 26643744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters